Skip to main content
SpringerLink
Log in
Book cover

Clinical Research in Gastroenterology 2 pp 31–50Cite as

Conservative treatment of Crohn’s disease

  • Chapter

  • 40 Accesses

Abstract

Crohn’s disease is a disease of modern Western civilization; it has experienced a tremendous increase since 1960. Incidence rates in Northern Europe and the United States are now up to 8.8/100 000 inhabitants per year and prevalence rates up to 106/100 000 inhabitants (Table 3.1). Despite very extensive investigation, the aetiology of Crohn’s disease remains unknown and, in consequence, to date no causal therapy exists. Thus Dr Crohn’s statement made in 1932 is still valid and true: ‘Medical treatment is purely palliative and supportive’1.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Crohn, B.B., Ginzburg, L. and Oppenheimer, G.D. (1932). Regional ileitis. A pathological and clinical entity. J. Am. Med. Assoc., 99, 1323–9

    Google Scholar 

  2. Kyle, J. (1971). An epidemiological study of Crohn’s disease in North East Scotland. Gastroenterology, 61, 826–33

    PubMed  CAS  Google Scholar 

  3. Binder, V., Both, H., Hansen, P.K. et al. (1982). Incidence and prevalence of ulcerative colitis and Crohn’s disease in the County of Kopenhagen 1962–1978. Gastroenterology, 83, 563–8

    PubMed  CAS  Google Scholar 

  4. Miller, D.S., Keighly, A.C. and Langman, M.J.S. (1974). Changing patterns in epidemiology of Crohn’s disease. Lancet, 2, 691–3

    Article  PubMed  CAS  Google Scholar 

  5. Mayberry, J.F., Rhodes, J. and Hughes, L.E. (1979). Incidence of Crohn’s disease in Cardiff between 1934 and 1977. Gut, 20, 602–8

    Article  PubMed  CAS  Google Scholar 

  6. Goebell, H., Dirks, E. and Förster, S. (1987). Prospective analysis of the frequency of chronic inflammatory bowel disease in an urban population (Ruhr Area). In: Goebell, H., Peskar, B.M. and Malchow, H. (eds.) Inflammatory Bowel Disease, pp. 241–2. (Lancaster: MTP Press)

    Google Scholar 

  7. Nylin, H. and Danielsson, A. (1986). Incidence of Crohn’s disease in a defined population in Northern Sweden, 1974–1981. Scand. J. Gastroenterol., 21, 1185–92

    Article  Google Scholar 

  8. Heller, G. (1979). Crohn’s disease in Stockholm County 1955–1974. A study of epidemiology, results of surgical treatment and long-term prognosis. Act. Chir. Scand., 490 (suppl.), 1–84

    Google Scholar 

  9. Brahme, F., Lindstrom, C. and Wenckert, A. (1975). Crohn’s disease in a defined population. An epidemiological study of incidence, prevalence, mortality and secular trends in the city of Malmö, Sweden. Gastroenterology, 69, 342–51

    PubMed  CAS  Google Scholar 

  10. Sedleck, R.E., Whisnant, J., Elveback, L.R. et al. (1980). Incidence of Crohn’s disease in Olmsted County, Minnesota, 1935–1975. Am. J. Epidemiol., 112, 759–63

    Google Scholar 

  11. Nunes, G.C. and Ahlquist, R.E. (1983). Increasing incidence of Crohn’s disease. Am. J. Surg., 145, 578–81

    Article  PubMed  CAS  Google Scholar 

  12. Best, W.R., Becktel, J.M., Singleton, J.W. and Kern, F. (1976). Development of a Crohn’s Disease Activity Index. Gastroenterology, 70, 439–44

    PubMed  CAS  Google Scholar 

  13. Van Hees, P.A.M., Van Eiteren, P.H., van Lier, HJJ. and van Tongeren, J.H.M. (1980). An index of inflammatory activity in patients with Crohn’s disease. Gut, 21, 279–86

    Article  PubMed  Google Scholar 

  14. Harvey, R.F. and Bradshaw, J.M. (1980). A simple index of Crohn’s disease activity. Lancet, 1, 514–5

    Article  PubMed  CAS  Google Scholar 

  15. Martini, GA and Brandes, J.W. (1976). Increased consumption of refined carbohydrates in patients with Crohn’s disease. Klin. Wschr., 54, 367–71

    Article  PubMed  CAS  Google Scholar 

  16. Thornton, J.R., Emmet, P.M. and Heaton, K.W. (1979). Diet and Crohn’s disease: characteristics of the pre-illness diet. Br. Med. J., 2, 762–4

    Article  PubMed  CAS  Google Scholar 

  17. Heaton, K.W., Thornton, J.R. and Emmet, P.M. (1979). Treatment of Crohn’s disease with an unrefined-carbohydrate fibre-rich diet. Br. Med. J., 2, 764–6

    Article  PubMed  CAS  Google Scholar 

  18. Brandes, J.W. and Lorenz-Meyer, H. (1981). Zuckerfreie Diät: Eine neue Perspektive zur Behandlung des Morbus Crohn? Z. Gastroenterol., 19, 1–12

    PubMed  CAS  Google Scholar 

  19. Ritchie, J.K., Wadsworth, J., Lennard-Jones, J.E. and Rogers, E. (1987). Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre-rich diet in Crohn’s disease. Br. Med. J., 295, 517–20

    Article  CAS  Google Scholar 

  20. Levenstein, S., Prantera, C., Luzi, C. and D’Ubaldi, A. (1985). Low residue or normal diet in Crohn’s disease: a prospective controlled study in Italian patients. Gut, 26, 989–93

    Article  PubMed  CAS  Google Scholar 

  21. Jones, V.A., Workman, E., Freeman, A.H., Dickinson, R.J., Wilson, A.J. and Hunter, J.O. (1985). Crohn’s disease: Maintenance of remission by diet. Lancet, 2, 177–80

    Article  PubMed  CAS  Google Scholar 

  22. Driscoll, R.H. and Rosenberg, I.H. (1978). Total parenteral nutrition in inflammatory bowel disease. Med. Clin. North Am., 62, 185–201

    PubMed  Google Scholar 

  23. Voitk, A.J., Echave, V., Feller, J.H. et al. (1973). Experience with elemental diet in the treatment of inflammatory bowel disease. Arch. Surg., 107, 329–33

    PubMed  CAS  Google Scholar 

  24. Morin, C.L., Roulet, M., Weber, A., Roy, C.C. et al. (1979). Nasogastric infusion of elemental diet (ED) as a primary therapy in Crohn’s disease. Pediatr. Res., 13, 405 (abstract)

    Google Scholar 

  25. Hylander, E. and Jarnum, S. (1980). Klinische Erfahrungen mit Elementardiäten bei gastro-intestinalen Erkrankungen. Akt. Ernährungsmed, 5, 105–7

    Google Scholar 

  26. Lochs, H.M., Egger-Schödl, M., Schuh, R. et al. (1984). Is tube feeding with elemental diets a primary therapy of Crohn’s disease? Klin. Wschr., 62, 821–5

    Article  PubMed  CAS  Google Scholar 

  27. Teahon, K., Bjarnason, I. and Levi, A.J. (1988). Elemental diet in the management of Crohn’s disease. A 10-year review. Gastroenterology, 94, A457

    Google Scholar 

  28. Bos, L.P. and Weterman, I.T. (1980). Total parenteral nutrition in Crohn’s disease. World J. Surg., 4, 163–6

    Article  PubMed  CAS  Google Scholar 

  29. Reilly, J., Ryan, JA., Strole, W. and Fischer, J.E. (1976). Hyperalimentation in inflammatory bowel disease. Am. J. Surg., 131, 192–200

    Article  PubMed  CAS  Google Scholar 

  30. Elson, C.O., Layden, T.J., Nemchausky, BA. (1980). An evaluation of total parenteral nutrition in the management of inflammatory bowel disease. Dig. Dis. Sci., 25, 42–8

    Article  PubMed  CAS  Google Scholar 

  31. Ostro, M.J., Greenberg, J.R. and Jeejeebhoy, K.N. (1985). Total parenteral nutrition and complete bowel rest in the management of Crohn’s disease. J. Parent. Ent. Nutr., 9, 280–7

    Article  CAS  Google Scholar 

  32. Müller, J.M., Keller, H.W., Erasmi, H. and Pichlmaier, H. (1983). Total parenteral nutrition as the sole therapy in Crohn’s disease — a prospective study. Br. J. Surg., 70, 40–3

    Article  PubMed  Google Scholar 

  33. Shiloni, E. and Freund, H.R. (1983). Total parenteral nutrition in Crohn’s disease. Is it a primary or supportive mode of therapy? Dis. Colon Rectum, 26, 275–8

    Article  PubMed  CAS  Google Scholar 

  34. Dickinson, R.J., Ashton, M.G., Axon, A.T.R. et al. (1980). Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology, 79, 1199–204

    PubMed  CAS  Google Scholar 

  35. Greenberg, G.R., Fleming, C.R., Jeejeebhoy, K.N. et al. (1985). Controlled trial of bowel rest and nutritional support in the management of Crohn’s disease. Gastroenterology, 88, 1405 (abstract)

    Google Scholar 

  36. Mclntyre, P.B., Powell-Tuck, J., Wood, S.R. et al. (1986). Controlled trial of bowel rest in the treatment of severe acute colitis. Gut, 27, 481–5

    Article  Google Scholar 

  37. O’Morain, C., Segal, A.W. and Levi, A.J. (1984). Elemental diet as a primary treatment of acute Crohn’s disease: a controlled trial. Br. Med. J., 288, 1859–62

    Article  Google Scholar 

  38. Saverymuttu, S., Hodgson, H.J.F. and Chadwick, V.S. (1985). Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn’s disease. Gut, 26, 994–8

    Article  PubMed  CAS  Google Scholar 

  39. Sanderson, I.R., Udeen, S., Davies, P.S.W, et al. (1987). Remission induced by an elemental diet in small bowel Crohn’s disease. Arch. Dis. Child., 61, 123–7

    Article  Google Scholar 

  40. Malchow, H., Steinhardt, H.J., Strohm, W.D. et al. (1985). Feasibility and effectiveness of a defined formula diet regimen in treating active Crohn’s disease. Gastroenterology, 88, 1487 (abstract)

    Google Scholar 

  41. Lochs, H., Steinhardt, H.J., Klaus-Wenz, B. et al. (1988). Enteral nutrition versus drug treatment for the acute phase of Crohn’s disease: Results of the European Co-operative Crohn’s Disease Study IV. Gastroenterology, 94, A267

    Google Scholar 

  42. Summers, R.W., Switz, D.M., Sessions, J.T. et al. (1979). National Co-operative Crohn’s Disease Study, results of drug treatment. Gastroenterology, 77, 847–69

    PubMed  CAS  Google Scholar 

  43. Malchow, H., Ewe, K., Brandes, J.W., Goebell, H. et al. (1984). European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology, 86, 249–66

    PubMed  CAS  Google Scholar 

  44. Singleton, J.W., Summers, R.W., Kern, F. et al. (1979). A trial of sulfasalazine as adjunctive therapy in Crohn’s disease. Gastroenterology, 77, 887–97

    PubMed  CAS  Google Scholar 

  45. Smith, R.C., Rhodes, J., Heatley, R.V. et al. (1978). Low dose steroids and clinical relapse in Crohn’s disease: a controlled trial. Gut, 19, 606–10

    Article  PubMed  CAS  Google Scholar 

  46. Bergman, L. and Krause, U. (1976). Postoperative treatment with corticosteroids and salazosulphapyridine (salazopyrin) after radical resection for Crohn’s disease. Scand. J. Gastroenterol., 11, 651–6

    PubMed  CAS  Google Scholar 

  47. Anthonisen, P., Barany, F., Folkenborg, O. et al. (1974). The clinical effect of salazosulphapyridine (salazopyrin) in Crohn’s disease. Scand. J. Gastroenterol., 9, 549–54

    PubMed  CAS  Google Scholar 

  48. Van Hees, P.A.M, van Lier, H.J.J., van Eiteren, P.H., Driessen, W.M.M., van Hogezand, RA. et al. (1981). Effect of sulphasalazine in patients with active Crohn’s disease: a controlled double blind study. Gut, 22, 404–9

    Article  PubMed  Google Scholar 

  49. Baron, J.H., Bennett, P.N., Lennard-Jones, J.E. et al. (1977). Sulphasalazine in asymptomatic Crohn’s disease. A multicentre trial. Gut, 18, 69–72

    Article  Google Scholar 

  50. Wenckert, A., Kristensen, M., Eklund, A.E. et al. (1978). The long-term prophylactic effect of salazosulphapyridine (salazopyrin) in primarily resected patients with Crohn’s disease. Scand. J. Gastroenterol., 13, 161–7

    Article  PubMed  CAS  Google Scholar 

  51. Ewe, K., Malchow, H. and Herfarth, Ch. (1985). Operative Radikalität und Rezidivprophylaxe mit Azulfidine bei Morbus Crohn: Ein prospektive multicentrische Studie. Langenbecks Arch. Chir., 364, 427–30

    Article  Google Scholar 

  52. Rhodes, J., Beck, P., Bainton, D. and Campbell, H. (1971). Controlled trial of azathioprine in Crohn’s disease. Lancet, 12, 1273–6

    Article  Google Scholar 

  53. Klein, M., Binder, H.J., Mitchel, M et al. (1974). Treatment of Crohn’s disease with azathioprine: a controlled evaluation. Gastroenterology, 66, 916–22

    PubMed  CAS  Google Scholar 

  54. Watson, W.C. and Bukowsky, M. (1974). Azathioprine in management of Crohn’s disease: a randomized crossover study. Gastroenterology, 66, A142

    Google Scholar 

  55. Rosenberg, J.L., Levin, B., Wall, A.J. and Kirsner, J.B. (1975). A controlled trial of azathioprine in Crohn’s disease. Dig. Dis., 20, 721–6

    Article  CAS  Google Scholar 

  56. Willoughby, J.M.T., Beckett, J., Kumar, P J. et al. (1971). Controlled trial of azathioprine in Crohn’s disease. Lancet, 2, 944–6

    Article  PubMed  CAS  Google Scholar 

  57. O’Donnoghue, D.P., Dawson, A.M., Powell-Tuck, J. et al. (1978). Double blind withdrawal trial of azathioprine as maintenance treatment for Crohn’s disease. Lancet, 2, 955–7

    Article  Google Scholar 

  58. Nyman, M., Hansson, I. and Eriksson, S. (1985). Long-term immunosupressive treatment in Crohn’s disease. Scand. J. Gastroenterol., 20, 1197–203

    Article  PubMed  CAS  Google Scholar 

  59. Present, D.H., Korelitz, B.I., Wisch, N. et al. (1980). Treatment of Crohn’s disease with 6-mercaptopurine. N. Engl. J. Med., 302, 981–7

    Article  PubMed  CAS  Google Scholar 

  60. Korelitz, B.I. and Present, D.H. (1985). Favorable effect of 6-mercaptopurine on fistulae of Crohn’s disease. Dig. Dis. Sci., 30, 58–64

    Article  PubMed  CAS  Google Scholar 

  61. Singleton, J.W., Law, D.H., Kelley, M.L. et al. (1979). National Co-operative Crohn’s Disease Study: adverse reaction to study drugs. Gastroenterology, 77, 870–82

    PubMed  CAS  Google Scholar 

  62. Rosen, A., Ursing, B., Alm, Th., Barany, F. et al. (1982). A comparative study of metronidazole and sulfasalazine for active Crohn’s disease: The Co-operative Crohn’s Disease Study in Sweden. Gastroenterology, 83, 541–9

    PubMed  CAS  Google Scholar 

  63. Bernstein, L.H., Frank, M.S., Brandt, L.J. et al. (1980). Healing of perineal Crohn’s disease with metronidazole. Gastroenterology, 79, 357–65

    PubMed  CAS  Google Scholar 

  64. Schneider, M.U., Laudage, G., Guggenmoos-Holzmann, I. and Riemann, J.F. (1985). Metronidazol in der Behandlung des Morbus Crohn. Dtsch. Med. Wschr., 110, 1724–30

    Article  PubMed  CAS  Google Scholar 

  65. Rasmussen, S.N., Bondesen, S., Hvidberg, E.F. et al. (1982). 5-Aminosalicylic acid in a slow release preparation: Bioavailability, plasma level and excretion in humans. Gastroenterology, 83, 1062–70

    PubMed  CAS  Google Scholar 

  66. Rasmussen, S.N., Binder, V., Maier, K. et al. (1983). Treatment of Crohn’s disease with peroral 5-aminosalicylic acid. Gastroenterology, 85, 1350–3

    PubMed  CAS  Google Scholar 

  67. Maier, K., Frühmorgen, P., Bode, J. Ch. et al. (1985). Erfolgreiche Akutbehandlung chronisch-entzündlicher Darmerkrankungen mit oraler 5-Aminosalicylsäure. Dtsch. Med. Wschr., 110, 363–8

    Article  PubMed  CAS  Google Scholar 

  68. Saverymuttu, S.H., Gupta, S., Keshavarzian, A. et al. (1986). Effect of a slow release 5-aminosalicylic acid preparation on disease activity in Crohn’s disease. Digestion, 33, 89–91

    Article  PubMed  CAS  Google Scholar 

  69. Rasmussen, S.N., Lauritsen, K., Tage-Jensen, U. et al. (1987). 5-Aminosalicylic acid in the treatment of Crohn’s disease. Scand. J. Gastroenterol., 22, 877–33

    Article  PubMed  CAS  Google Scholar 

  70. Jenss, H., Hartmann, F. and Schölmerich, J. (1988). Therapie des aktiven Morbus Crohn mit 5-Aminosalicylsäure oder Methylprednisolon. Z. Gastroenterol., (Abstract) 24, 473

    Google Scholar 

  71. Segal, A.W., Levi, A.J. and Loewi, G. (1977). Levamisole in the treatment of Crohn’s disease. Lancet, 2, 382–4

    Article  PubMed  CAS  Google Scholar 

  72. Wesdorp, E., Schellekens, P.T.A., Weening, R et al. (1978). Levamisole in Crohn’s disease. Digestion, 18, 186–91

    Article  PubMed  CAS  Google Scholar 

  73. Sachar, D.B., Rubin, K.P. and Gumaste, V. (1987). Levamisole in Crohn’s disease: a randomized, double-blind, placebo-controlled clinical trial. Am. J. Gastroenterol., 82, 536–9

    PubMed  CAS  Google Scholar 

  74. Modigliani, R, Pieddeloup, C., Hecketsweiler, P. et al. (1983). Effet du levamisole sur la prevention des pousees évolutives de la maladie de Crohn quiescente. Gastroenterol. Clin. Biol., 7, 683–92

    PubMed  CAS  Google Scholar 

  75. Rohr, G., Kusterer, K, Schule, M. et al. (1987). Treatment of Crohn’s disease and ulcerative colitis with 7S-immunoglobulin. Lancet, 1, 170 (letter)

    Article  PubMed  CAS  Google Scholar 

  76. Allison, M.C. and Pounder, RE. (1984). Cyclosporin for Crohn’s disease. Lancet, 1, 902–3 (letter)

    Article  PubMed  CAS  Google Scholar 

  77. Peltekian, K.M., Williams, C.N., MacDonald, A.S. et al. (1987). Open study of cyclosporin A in Crohn’s disease. Gastroenterology, 92, 1571 (abstract)

    Google Scholar 

  78. Brynskov, J., Binder, V., Riis, P. et al. (1987). Clinical experience with cyclosporin (cyclosporin A) in chronically-active, therapy-resistant Crohn’s disease. A pilot study. Gastroenterology, 92, 1330 (abstract)

    Google Scholar 

  79. Allison, M.C. and Pounder, RE. (1987). Cyclosporin for Crohn’s disease. Aliment. Pharmacol. Ther., 1, 39–43

    Article  PubMed  CAS  Google Scholar 

  80. Chiodini, R.J., van Kruiningen, H.J., Thayer, W.R, Merkal, R.S. and Coutu, J.A. (1984). Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified mycobacterium species isolated from patients with Crohn’s disease. Dig. Dis. Sci., 29, 1073–9

    Article  PubMed  CAS  Google Scholar 

  81. McFadden J.J., Butcher, P.D., Chiodini, R and Hermon-Taylor, J. (1987). Crohn’s disease isolated mycobacteria are identical to Mycobacterium paratuberculosis, as determined by DNA-probes that distinguish between mycobacterial species. J. Clin. Microbiol., 25, 796–801

    PubMed  CAS  Google Scholar 

  82. Gitnick, G. (1984). Is Crohn’s disease a mycobacterial disease after all? Dig. Dis. Sci., 25, 1086–8

    Article  Google Scholar 

  83. Rutgerts, P., Vantrappen, G., Van Meldt, K et al. (1988). Rifabutin therapy in patients with recurrent Crohn’s disease after ileocolonic resection. Gastroenterology, 94, A391

    Google Scholar 

  84. Thayer, W.R., Coutu, J.A., Chiodini, R.A. et al. (1988). Use of rifabutin and streptomycin in the therapy of Crohn’s disease. Gastroenterology, 94, A458

    Google Scholar 

  85. Hampson, S.J., Parker, M.C., Saverymuttu, S.H. et al (1988). Results of quadruple antimycobacterial chemotherapy in 17 Crohn’s disease patients completing six months treatment. Gastroenterology, 94, A170

    Google Scholar 

Download references

Authors
  1. H. Wietholtz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. J. Thon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Büchsel
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Matern
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Faculty of Aachen University of Technology, Aachen, Germany

    S. Matern (Director of the Third Department of Internal Medicine) (Director of the Third Department of Internal Medicine)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Kluwer Academic Publishers

About this chapter

Cite this chapter

Wietholtz, H., Thon, H.J., Büchsel, R., Matern, S. (1989). Conservative treatment of Crohn’s disease. In: Matern, S. (eds) Clinical Research in Gastroenterology 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2488-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-2488-8_3

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7622-7

  • Online ISBN: 978-94-009-2488-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation